Q4 2024 Holdings
Filed 2025-02-14 | 108 holdings | $553.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $34.6M | 1,569,181 | 6.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $24.8M | 905,279 | 4.5% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $18.5M | 384,515 | 3.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $18.3M | 1,381,241 | 3.3% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $14.7M | 225,060 | 2.7% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $13.7M | 62,607 | 2.5% |
| Nova LTD(NVMI) | COM | M7516K103 | $13.4M | 68,146 | 2.4% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $12.3M | 21,001 | 2.2% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $12.0M | 98,921 | 2.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $12.0M | 474,103 | 2.2% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $10.5M | 2,551,619 | 1.9% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $10.2M | 13,190 | 1.8% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $10.1M | 69,831 | 1.8% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $9.6M | 228,776 | 1.7% |
| Microsoft Corp(MSFT) | COM | 594918104 | $9.4M | 22,327 | 1.7% |
| Marvell Technology Inc(MRVL) | COM | 573874104 | $8.7M | 78,611 | 1.6% |
| Tower Semiconductor LTD(TSEM) | SHS NEW | M87915274 | $8.6M | 166,149 | 1.5% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $8.4M | 98,080 | 1.5% |
| WIX COM LTD(WIX) | SHS | M98068105 | $8.4M | 39,253 | 1.5% |
| Alphabet Inc(GOOG) | CAP STK CL C | 02079K107 | $8.3M | 43,500 | 1.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $7.4M | 388,183 | 1.3% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $7.2M | 42,500 | 1.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.2M | 153,021 | 1.3% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $7.0M | 91,583 | 1.3% |
| Check Point Software Tech LT(CHKP) | ORD | M22465104 | $6.7M | 35,635 | 1.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $6.6M | 206,251 | 1.2% |
| Immatics N.v(IMTX) | SHS | N44445109 | $6.5M | 921,111 | 1.2% |
| Praxis Precision Medicines I(PRAX)Call | COM NEW | 74006W207 | $6.4M | 83,000 | 1.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $6.4M | 1,243,039 | 1.2% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $6.1M | 34,256 | 1.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $5.9M | 59,600 | 1.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $5.8M | 156,494 | 1.1% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $5.7M | 1,165,895 | 1.0% |
| Jfrog LTD(FROG) | ORD SHS | M6191J100 | $5.6M | 190,381 | 1.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $5.6M | 236,262 | 1.0% |
| Merus N V | COM | N5749R100 | $5.5M | 130,532 | 1.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $5.4M | 466,080 | 1.0% |
| Ormat Technologies Inc(ORA) | COM | 686688102 | $5.3M | 79,000 | 1.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $5.3M | 610,087 | 1.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $5.3M | 288,539 | 1.0% |
| Solaredge Technologies Inc(SEDG) | COM | 83417M104 | $5.1M | 375,000 | 0.9% |
| Ormat Technologies Inc | DEBT 2.500% 7/1 | 686688AC6 | $5.0M | 5,037,000 | 0.9% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $4.9M | 50,000 | 0.9% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $4.7M | 538,111 | 0.9% |
| Skye Bioscience Inc(SKYE) | COM NEW | 83086J200 | $4.4M | 1,564,628 | 0.8% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $4.4M | 130,000 | 0.8% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $4.4M | 556,532 | 0.8% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $4.3M | 581,829 | 0.8% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $4.2M | 334,987 | 0.8% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.2M | 103,270 | 0.8% |